Published on: 

Hospira One 2 One®: contract development and fill-finish manufacturing of injectable products packaged in vials, PFS, cartridges, ampoules.

Hospira’s One 2 One® business is a world leader in the custom development and manufacture of parenteral products packaged in vials, prefilled syringes, cartridges, flexible containers and ampoules. Whether your product is a small molecule or advanced biologic, One 2 One’s highly qualified personnel in every world-class facility ensure quality, capacity and security of supply.

Technical Services
One2One is able to manufacture injectable products in a broad range of delivery systems including:

  • Vials, bottles and ampoules
  • Prefilled glass or plastic syringes
  • Cartridges for self-administration devices
  • Onco-tain™ cytotoxic containment vial
  • Flexible Containers

One2One has the ability to manufacture a variety of injectable products, and has a broad range of capabilities:

  • Biologics
  • Vaccines
  • Beta-lactams
  • Cytotoxics
  • Controlled Substances
  • Potent drugs
  • Suspensions
  • Emulsions/lips
  • Lyophilization
  • Sterile Powder Filling
  • Terminal Sterilization
  • Irradiation Sterilization
  • Disposable Compounding Equipment
  • Multilingual packaging and labeling
  • Cold chain management

One2One primarily works with five parenteralmanufacturing facilities in North America, Europeand the Asia Pacific regions, each registeredwith multiple regulatory agencies worldwide:

  • McPherson, Kansas, USA: A leader in biologics fill–finish
  • Liscate, Italy: Small molecules and biologics fill-finish
  • Zagreb, Croatia: Biologics fill-finish
  • Chennai, India: Beta-lactam powder filling
  • Mulgrave (Melbourne), Australia: Cytotoxic fill–finish